Navigation Links
Bio-Optronics Incorporates RxPaying(TM) Patient Stipend Debit Card Feature in Clinical Conductor(TM) Clinical Trial Management System (CTMS)
Date:4/21/2009

ROCHESTER, N.Y., April 21 /PRNewswire/ -- Bio-Optronics, Inc. will enhance its Clinical Conductor(TM) Clinical Trial Management System with click-through integration to Interspond's RxPaying(TM) debit card solution. This offers a patient stipend payment alternative which improves efficiency and increases patient satisfaction. Clinical Conductor(TM) CTMS provides natural points in clinical trial workflow into which best-in-class tools and expertise can be integrated seamlessly. Dan Kerpelman, President and CEO states, "We are pleased to be integrating RxPaying(TM) debit cards as an efficient alternative to the patient stipend payment process and will continue to leverage Clinical Conductor(TM) as the entry point for seamless integration to tools that optimize efficiency, productivity, and improve collaboration across the clinical environment."

Clinical Conductor(TM) CTMS, proven to improve site efficiency and productivity, handles the complete enterprise workflow, from business development, to patient databases, recruitment, scheduling, workload planning, finances, and complete oversight and reporting, and provides an innovative Electronic Data Capture option. The academic medical center clinical trial management system solution adds research administration capabilities and custom interfaces to hospital enterprise systems.

The Rx Paying(TM) Debit Card helps ensure higher patient participation and retention by providing immediate access to their funds, which can be used to purchase items, request cash back from a purchase or get cash from an ATM. It centralizes the process of patient reimbursement for clinical studies as a whole. "Integrating RxPaying(TM) with Clinical Conductor(TM), one of the leading CTMS in the industry, is a natural fit and we are excited about our partnership. While both products are excellent stand-alone systems, the integration creates a more dynamic product by eliminating redundancy and streamlining the reimbursement process," according to Kathy S. Cox, President & CEO of Interspond.

Bio-Optronics, Inc. develops, deploys, and operates software products and custom information technology solutions to help healthcare professionals manage and optimize workflow, thus enhancing quality, productivity, and patient and staff satisfaction. For over 20 years, Bio-Optronics has demonstrated leadership in innovation, expertise in workflow and integration, and a singular approach to unparalleled customer service. Our workflow solutions are used in over 30 Veterans' Administration and other hospitals in the U.S., and over 400 clinical research sites around the world. www.bio-optronics.com

Interspond is a Trial Management Organization (TMO) for the pharmaceutical and biotechnology industries working to identify study opportunities for sites' participation. We maintain a database of hundreds of qualified, experienced investigative sites capable of conducting Phase I through Phase IV studies. These sites are located throughout the country and are multi-therapeutic in nature. Our RxPaying(TM) service offers electronic reimbursement for the clinical research industry. RxPaying(TM) streamlines and simplifies the process of reimbursing patients for participation in clinical research studies through the use of an instant issue debit card. www.interspond.com

CONTACT: Bio-Optronics, (877) 279-8377, www.bio-optronics.com; Maria Durkin, VP, Director Marketing and Operations, mdurkin@bio-optronics.com


'/>"/>
SOURCE Bio-Optronics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Health Management Corporation Incorporates Clinically Proven Care Diabetes Management Program With Programming From dLife
2. ASA plus clopidogrel reduces heart attack risk in patients with acute coronary syndrome
3. First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure
4. Surveyed Specialists Foresee Greater Use of Parenteral Outpatient Therapy for the Treatment of Osteomyelitis
5. WakeMed Shares Best Practices for Tracking Assets, Patients
6. Tragic choices: Is it better for doctors or patient families to decide?
7. Thomson Reuters Study Finds More Patients Postponing Medical Care Due to Cost
8. Genetic variants predict recurrence of bladder cancer, patient survival
9. Acupuncture eases radiation-induced dry mouth in cancer patients
10. Doctor-Patient Talks Key to Blacks Getting Cancer Screens
11. PatientCentral Technologies, LLC and VerdaSee Solutions, Inc. Team Up With Congressional Staff in Washington, DC for Disaster Preparedness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Tingley Rubber ... Canada to provide its range of unique and advantaged protective solutions to ... that will provide bilingual customer service and marketing support. A new distribution center ...
(Date:2/8/2016)... (PRWEB) , ... February 08, ... ... and security executive networking and relationship-marketing firm, announced today that nominations will ... Information Security Executive® (ISE®) West Awards. , Awards include the Information ...
(Date:2/8/2016)... ... February 08, 2016 , ... GrassrootsHealth published data from its ... 2 diabetes in the GrassrootsHealth cohort with substantially higher vitamin D levels than ... public health,” states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is ... this country. The AutismOne 2016 Conference, which is being held May 25-29 at the ... hear elsewhere about helpful interventions and causes of chronic illness in children. , Very ...
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd ... to his medical and surgical expertise. Technically known as deoxycholic acid or previously ... as a non-surgical alternative for reduction of fat below the chin (aka the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016  The University of ... announced today that, as part of the development ... of the first hospitals in the U.S. to start ... Muraszko , M.D., U-M,s chair of neurosurgery. ... neurosurgery. --> The BrightMatter technology from ...
(Date:2/8/2016)... CITY, Calif., Feb. 8, 2016  Aoxing Pharmaceutical Company, Inc. (NYSE ... fiscal year 2016, ended December 31, 2015, the Company achieved ... recorded in the same quarter in fiscal 2015. ... in Q2 of fiscal year 2016 was $2,068,635, or $.03 ... or $.01 per share, in the Q2 of fiscal year ...
(Date:2/8/2016)... Feb. 8, 2016 ... of the "Label-Free Detection Market by ... 2020" report to their offering. ... addition of the "Label-Free Detection Market ... to 2020" report to their offering. ...
Breaking Medicine Technology: